APOE and Alzheimer disease: Genetic information, available for 58 of the participants with DS, was used to assess the effects of apolipoprotein E (APOE) genotype and the AD‐associated SNPs rs11136000 (CLU), rs6656401, rs6691117 (CR1) on complement protein levels in DS.